Jumadil, Baby Boy .
HRN: 24-79-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2024
AMPICILLIN 250MG (VIAL)
04/07/2024
04/13/2024
IV
180mg
Q12h
T/c Sepsis; T/c Hemorrhagic Disease Of Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes